IL133913A0 - Treatment of inflammatory disorders of the bowel and urinary bladder - Google Patents
Treatment of inflammatory disorders of the bowel and urinary bladderInfo
- Publication number
- IL133913A0 IL133913A0 IL13391398A IL13391398A IL133913A0 IL 133913 A0 IL133913 A0 IL 133913A0 IL 13391398 A IL13391398 A IL 13391398A IL 13391398 A IL13391398 A IL 13391398A IL 133913 A0 IL133913 A0 IL 133913A0
- Authority
- IL
- Israel
- Prior art keywords
- inflammatory disorders
- bowel
- treatment
- urinary bladder
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
- A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0439—White blood cells; Leucocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
- A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5210197P | 1997-07-10 | 1997-07-10 | |
PCT/US1998/014118 WO1999002215A1 (en) | 1997-07-10 | 1998-07-08 | Treatment of inflammatory disorders of the bowel and urinary bladder |
Publications (1)
Publication Number | Publication Date |
---|---|
IL133913A0 true IL133913A0 (en) | 2001-04-30 |
Family
ID=21975478
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13391398A IL133913A0 (en) | 1997-07-10 | 1998-07-08 | Treatment of inflammatory disorders of the bowel and urinary bladder |
IL133913A IL133913A (en) | 1997-07-10 | 2000-01-06 | Treatment of inflammatory disorders of the bowel and urinary bladder |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL133913A IL133913A (en) | 1997-07-10 | 2000-01-06 | Treatment of inflammatory disorders of the bowel and urinary bladder |
Country Status (19)
Country | Link |
---|---|
US (1) | US5985914A (da) |
EP (1) | EP0994743B1 (da) |
JP (1) | JP4166432B2 (da) |
KR (1) | KR100541784B1 (da) |
CN (1) | CN1230212C (da) |
AT (1) | ATE327800T1 (da) |
AU (1) | AU752616B2 (da) |
CA (1) | CA2295572C (da) |
DE (1) | DE69834724T2 (da) |
DK (1) | DK0994743T3 (da) |
ES (1) | ES2265664T3 (da) |
HK (1) | HK1030891A1 (da) |
HU (1) | HUP0004089A2 (da) |
IL (2) | IL133913A0 (da) |
NO (1) | NO20000087L (da) |
NZ (1) | NZ524459A (da) |
PL (1) | PL196145B1 (da) |
PT (1) | PT994743E (da) |
WO (1) | WO1999002215A1 (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2295572C (en) * | 1997-07-10 | 2010-07-06 | Therakos, Inc. | Treatment of inflammatory disorders of the bowel and urinary bladder |
US6495366B1 (en) | 1999-09-03 | 2002-12-17 | Therakos, Inc. | Uninterrupted flow pump apparatus and method |
US8722422B2 (en) | 1999-09-03 | 2014-05-13 | Therakos, Inc. | Uninterrupted flow pump apparatus and method |
US20050202098A1 (en) | 2001-01-31 | 2005-09-15 | Tolaren | Disease therapy using dying or dead cells |
AU2002230061A1 (en) * | 2001-01-31 | 2002-08-12 | Tolaren | Induction of tolerance by apoptotic and/or necrotic cells |
WO2003045979A2 (en) * | 2001-11-29 | 2003-06-05 | Therakos, Inc. | Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
US7479123B2 (en) | 2002-03-04 | 2009-01-20 | Therakos, Inc. | Method for collecting a desired blood component and performing a photopheresis treatment |
US20040127840A1 (en) | 2002-03-04 | 2004-07-01 | Steve Gara | Blood separation apparatus and method of using the same |
GB0216650D0 (en) * | 2002-07-18 | 2002-08-28 | Univ Bristol | Detection of disease by analysis of emissions |
WO2006060649A2 (en) * | 2004-12-02 | 2006-06-08 | Isis Pharmaceuticals, Inc. | Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease |
WO2007004045A2 (en) * | 2005-07-05 | 2007-01-11 | Universite De Lausanne | Use of a photosensitizing agent in the treatment or prevention of an inflammation-associated disorder in the gastrointestinal tract of a mammal |
ES2633102T3 (es) | 2005-11-02 | 2017-09-19 | Therakos, Inc. | El uso de células apoptóticas ex vivo para generar linfocitos T reguladores |
US20070264663A1 (en) | 2006-05-02 | 2007-11-15 | O'brien Peter J | Methods and reagents for detecting susceptibility to graft versus host disease or transplant related mortality |
EP2042179A1 (en) * | 2007-09-26 | 2009-04-01 | sanofi-aventis | Novel therapeutic uses of adrenergic alpha-1 receptor antagonists |
US9399093B2 (en) | 2012-01-27 | 2016-07-26 | Fenwal, Inc. | Systems and methods for performing online extracorporeal photopheresis |
DE102013101989A1 (de) * | 2013-02-28 | 2014-09-18 | B. Braun Avitum Ag | Fuzzy-Logik |
CN114901809A (zh) * | 2019-12-20 | 2022-08-12 | 马林克罗特制药爱尔兰有限公司 | 用于在血源性样品中产生免疫调节性细胞的方法 |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4196281A (en) * | 1976-10-20 | 1980-04-01 | Regents Of The University Of California | Psoralens |
IT1088554B (it) * | 1977-11-17 | 1985-06-10 | F I D I A Spa | Procedimento sellettivo per la preparazione di derivati della 7-indrossi cumarina |
US4428744A (en) * | 1979-12-11 | 1984-01-31 | Frederic A. Bourke, Jr. | Method and system for externally treating the blood |
US4398906A (en) * | 1979-12-11 | 1983-08-16 | Frederic A. Bourke, Jr. | Method for externally treating the blood |
US4321919A (en) * | 1979-12-11 | 1982-03-30 | Leukocyte Research, Inc. | Method and system for externally treating human blood |
US4464166A (en) * | 1981-06-12 | 1984-08-07 | Frederic A. Bourke, Jr. | Method for externally treating the blood |
US4612007A (en) * | 1981-06-16 | 1986-09-16 | Edelson Richard Leslie | Method and system for externally treating the blood |
FR2521999B1 (fr) * | 1982-02-25 | 1984-05-25 | Inst Nat Sante Rech Med | Pyrido (3',4' : 4,5) furo (3,2-g) coumarines ou pyrido (3,4-h) psoralenes, obtention, applications en cosmetologie et a titre de medicaments, et compositions cosmetiques et pharmaceutiques les contenant |
FR2521998B1 (fr) * | 1982-02-25 | 1985-10-25 | Inst Nat Sante Rech Med | Pyrido (3,4-c) psoralenes, obtention, applications en cosmetologie et a titre de medicaments et compositions cosmetiques et pharmaceutiques les contenant |
US4613322A (en) * | 1982-12-08 | 1986-09-23 | Edelson Richard Leslie | Method and system for externally treating the blood |
US4684521A (en) * | 1982-12-08 | 1987-08-04 | Frederic A. Bourke, Jr. | Method and system for externally treating the blood |
US4683889A (en) | 1983-03-29 | 1987-08-04 | Frederic A. Bourke, Jr. | Method and system for externally treating the blood |
US4748120A (en) * | 1983-05-02 | 1988-05-31 | Diamond Scientific Co. | Photochemical decontamination treatment of whole blood or blood components |
US5176921A (en) * | 1983-05-02 | 1993-01-05 | Diamond Scientific Co. | Method of blood component decontamination by glucose addition |
US4727027A (en) * | 1983-05-02 | 1988-02-23 | Diamond Scientific Co. | Photochemical decontamination treatment of whole blood or blood components |
US4693981A (en) * | 1983-12-20 | 1987-09-15 | Advanced Genetics Research Institute | Preparation of inactivated viral vaccines |
US4643710A (en) * | 1984-10-29 | 1987-02-17 | Mcneilab, Inc. | Valve apparatus for photoactivation patient treatment system |
US4578056A (en) * | 1984-10-29 | 1986-03-25 | Extracorporeal Medical Specialties, Inc. | Patient photopheresis treatment apparatus and method |
US4705498A (en) * | 1984-10-29 | 1987-11-10 | Mcneilab, Inc. | Disposable temperature probe for photoactivation patient treatment system |
US4573961A (en) * | 1984-10-29 | 1986-03-04 | Extracorporeal Medical Specialties, Inc. | Electronic control methods for puvapheresis apparatus |
US4573960A (en) * | 1984-10-29 | 1986-03-04 | Extracorporeal Medical Specialties, Inc. | Three phase irradiation treatment process |
US4692138A (en) * | 1984-10-29 | 1987-09-08 | Mcneilab, Inc. | Pump block for interfacing irradiation chamber to photoactivation patient treatment system |
US4596547A (en) * | 1984-10-29 | 1986-06-24 | Mcneilab, Inc. | Valve apparatus for photoactivation patient treatment system |
US4573962A (en) * | 1984-10-29 | 1986-03-04 | Extracorporeal Medical Specialties, Inc. | Cassette drawer assembly for photoactivation patient treatment system |
US4623328A (en) * | 1984-10-29 | 1986-11-18 | Mcneilab, Inc. | Pump monitor for photoactivation patient treatment system |
US4687464A (en) * | 1984-10-29 | 1987-08-18 | Mcneilab, Inc. | Zero insertion force socket for photoactivation patient treatment system |
US4708715A (en) * | 1984-10-29 | 1987-11-24 | Mcneilab, Inc. | Light array assembly for photoactivation patient treatment system |
US4568328A (en) * | 1984-10-29 | 1986-02-04 | Extracorporeal Medical Specialties, Inc. | Automated photophoresis blood portion control methods and apparatus |
US4681568A (en) * | 1984-10-29 | 1987-07-21 | Mcneilab, Inc. | Valve apparatus for photoactivation patient treatment system |
US4737140A (en) * | 1984-10-29 | 1988-04-12 | Mcneilab, Inc. | Irradiation chamber for photoactivation patient treatment system |
USD298279S (en) | 1986-02-27 | 1988-10-25 | Mcneilab, Inc. | Disposable patient fluid irradiation chamber |
US4897789A (en) * | 1986-02-27 | 1990-01-30 | Mcneilab, Inc. | Electronic device for authenticating and verifying disposable elements |
USD298567S (en) | 1986-02-27 | 1988-11-15 | Mcneilab, Inc. | Flexible patient fluid container |
USD299531S (en) | 1986-02-27 | 1989-01-24 | Mcneilab, Inc. | Patient photopheresis treatment unit |
USD299953S (en) | 1986-02-27 | 1989-02-21 | Mcneilab, Inc. | Control panel for a patient photophoresis treatment unit |
US4952812A (en) * | 1986-08-26 | 1990-08-28 | Baxter International Inc. | Irradiation of blood products |
US4866282A (en) * | 1986-08-26 | 1989-09-12 | Baxter International Inc. | Irradiation of blood products |
US4726949A (en) * | 1986-08-26 | 1988-02-23 | Baxter Travenol Laboratories, Inc. | Irradiation of blood products |
US4838852A (en) * | 1987-03-27 | 1989-06-13 | Therakos, Inc. | Active specific immune suppression |
US4878891A (en) * | 1987-06-25 | 1989-11-07 | Baylor Research Foundation | Method for eradicating infectious biological contaminants in body tissues |
US4960408A (en) * | 1989-01-10 | 1990-10-02 | Klainer Albert S | Treatment methods and vaccines for stimulating an immunological response against retroviruses |
US5216176A (en) * | 1989-01-23 | 1993-06-01 | Lehigh University | 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor |
US5356929A (en) * | 1989-01-23 | 1994-10-18 | Lehigh University | Reduced and quaternized psoralens as photo-activated therapeutics |
US4921473A (en) * | 1989-02-02 | 1990-05-01 | Therakos, Inc. | Multicomponent fluid separation and irradiation system |
US4999375A (en) * | 1989-04-11 | 1991-03-12 | Hoffmann-La Roche Inc. | Psoralen reagent compositions for extracorporeal treatment of blood |
US5383847A (en) * | 1990-03-29 | 1995-01-24 | Therakos, Inc. | Non-specific immune system enhancement |
CA2089005C (en) * | 1991-06-21 | 1999-01-19 | John Chapman | Method for inactivating pathogens in a body fluid |
EP0633786B1 (en) * | 1992-01-27 | 2001-08-01 | Baxter International Inc. | Method of inactivation of viral, parasitic and bacterial blood contaminants |
US5459030A (en) * | 1992-03-02 | 1995-10-17 | Steritech, Inc. | Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen |
US5288605A (en) * | 1992-03-02 | 1994-02-22 | Steritech, Inc. | Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
IL105741A0 (en) * | 1992-05-22 | 1993-09-22 | Genta Inc | Pharmaceutical compositions for treating cellular hyperproliferation using interleukin-1 inhibitory compounds |
CA2141803C (en) * | 1992-08-07 | 2003-06-17 | Lily Lin | Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
US5820872A (en) * | 1992-11-18 | 1998-10-13 | Yale University | Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor |
US5651993A (en) * | 1992-11-18 | 1997-07-29 | Yale University | Specific immune system modulation |
US5368841A (en) * | 1993-02-11 | 1994-11-29 | The General Hospital Corporation | Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides |
US5399719A (en) | 1993-06-28 | 1995-03-21 | Steritech, Inc. | Compounds for the photodecontamination of pathogens in blood |
CN1121217C (zh) * | 1996-03-29 | 2003-09-17 | 特拉科斯有限公司 | 免疫原性组合物 |
CA2295572C (en) * | 1997-07-10 | 2010-07-06 | Therakos, Inc. | Treatment of inflammatory disorders of the bowel and urinary bladder |
-
1998
- 1998-07-08 CA CA2295572A patent/CA2295572C/en not_active Expired - Lifetime
- 1998-07-08 HU HU0004089A patent/HUP0004089A2/hu unknown
- 1998-07-08 KR KR1020007000188A patent/KR100541784B1/ko not_active IP Right Cessation
- 1998-07-08 IL IL13391398A patent/IL133913A0/xx unknown
- 1998-07-08 PL PL338071A patent/PL196145B1/pl unknown
- 1998-07-08 US US09/111,829 patent/US5985914A/en not_active Expired - Lifetime
- 1998-07-08 CN CNB988070278A patent/CN1230212C/zh not_active Expired - Lifetime
- 1998-07-08 DK DK98934310T patent/DK0994743T3/da active
- 1998-07-08 EP EP98934310A patent/EP0994743B1/en not_active Expired - Lifetime
- 1998-07-08 NZ NZ524459A patent/NZ524459A/en not_active IP Right Cessation
- 1998-07-08 WO PCT/US1998/014118 patent/WO1999002215A1/en active IP Right Grant
- 1998-07-08 PT PT98934310T patent/PT994743E/pt unknown
- 1998-07-08 ES ES98934310T patent/ES2265664T3/es not_active Expired - Lifetime
- 1998-07-08 JP JP2000501803A patent/JP4166432B2/ja not_active Expired - Lifetime
- 1998-07-08 DE DE69834724T patent/DE69834724T2/de not_active Expired - Lifetime
- 1998-07-08 AU AU83864/98A patent/AU752616B2/en not_active Expired
- 1998-07-08 AT AT98934310T patent/ATE327800T1/de active
-
2000
- 2000-01-06 IL IL133913A patent/IL133913A/en not_active IP Right Cessation
- 2000-01-07 NO NO20000087A patent/NO20000087L/no not_active Application Discontinuation
-
2001
- 2001-03-12 HK HK01101782A patent/HK1030891A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR100541784B1 (ko) | 2006-01-10 |
AU8386498A (en) | 1999-02-08 |
IL133913A (en) | 2009-09-01 |
PL196145B1 (pl) | 2007-12-31 |
WO1999002215A1 (en) | 1999-01-21 |
DE69834724T2 (de) | 2007-05-24 |
CA2295572A1 (en) | 1999-01-21 |
NO20000087L (no) | 2000-03-09 |
PT994743E (pt) | 2006-08-31 |
HUP0004089A2 (hu) | 2001-04-28 |
NO20000087D0 (no) | 2000-01-07 |
CA2295572C (en) | 2010-07-06 |
JP4166432B2 (ja) | 2008-10-15 |
DE69834724D1 (de) | 2006-07-06 |
ATE327800T1 (de) | 2006-06-15 |
NZ524459A (en) | 2004-11-26 |
DK0994743T3 (da) | 2006-10-02 |
AU752616B2 (en) | 2002-09-26 |
ES2265664T3 (es) | 2007-02-16 |
CN1230212C (zh) | 2005-12-07 |
KR20010021630A (da) | 2001-03-15 |
US5985914A (en) | 1999-11-16 |
PL338071A1 (en) | 2000-09-25 |
EP0994743B1 (en) | 2006-05-31 |
EP0994743A1 (en) | 2000-04-26 |
HK1030891A1 (en) | 2001-05-25 |
JP2001509427A (ja) | 2001-07-24 |
EP0994743A4 (en) | 2001-02-14 |
CN1266375A (zh) | 2000-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1030891A1 (en) | Treatment of inflammatory disorders of the bowel and urinary bladder | |
IL126366A0 (en) | Photopheresis treatment of leukocytes | |
AU1373499A (en) | Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease | |
UA32429C2 (uk) | Засіб для лікування нетримання сечі | |
PL319370A1 (en) | Application of photodynamic therapy for selectively inactivating blood cells and treatment o diseases associated with immunological disturbances | |
UA84665C2 (ru) | Способ ингибирования опосредствованного ангиогенеза в ткани у пациента с неоваскулярным заболеванием роговицы | |
ES2164916T3 (es) | Tratamiento de la esclerosis multiple. | |
PL323798A1 (en) | Application of derivatives of vitamin d4 in treating skin diseases | |
AU2544197A (en) | Photopheresis treatment of chronic hcv infections | |
DE59600683D1 (de) | Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten | |
DE69716341D1 (de) | Verwendung von Alkanoyl-L-Carnitinen zur Herstellung eines Arzneimittels zur Behandlung von entzündlichen Darmerkrankungen | |
AU1601499A (en) | Citicoline to treat motor neuron diseases and demyelinating diseases | |
AU7373196A (en) | Combination of temozolomide and alpha-ifn for the treatment of advanced cancer | |
RU96114051A (ru) | Способ лечения экземы у травматолого-ортопедических больных с гнойной инфекцией | |
UA28207A (uk) | Спосіб лікування черепно-мозкової травми | |
RU95108457A (ru) | Способ лечения тяжелых форм глпс | |
RU95105085A (ru) | Способ воздействия на биологический объект | |
CA2199400A1 (en) | Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases | |
RU97111211A (ru) | Способ лечения больных с хирургическим эндотоксикозом | |
RU95105874A (ru) | Способ лечения острых тромбозов глубоких вен нижних конечностей | |
RU95100165A (ru) | Способ лечения прогрессирующей близорукости | |
RU96100139A (ru) | Способ лечения и профилактика заболеваний организма очищением от шлаков с помощью минеральных вод источников джил-су | |
CA2186752A1 (en) | Drug treatment of diseased sites deep within the body | |
UA33890A (uk) | Спосіб лікування хвороби пейроні | |
RU2000100938A (ru) | Лечение воспалительных заболеваний кишечника и мочевого пузыря |